CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)
China
· Delayed Price · Currency is CNY 7.37
-0.09 (-1.21%)
Apr 29, 2026, 3:04 PM CST
SHE:000908 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | -63.48 | -79.05 | 152.3 | -236.1 | -122.56 | -163.66 | Upgrade
|
| Depreciation & Amortization | 31.01 | 31.01 | 28.37 | 44.46 | 55.41 | 107.47 | Upgrade
|
| Other Amortization | 0.49 | 0.49 | 0.82 | 2.54 | 4.98 | 16.19 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.77 | 2.77 | 3.36 | -7.56 | -5.3 | -55.89 | Upgrade
|
| Asset Writedown & Restructuring Costs | 28.49 | 28.49 | 19.03 | 83.76 | 39.56 | 42.79 | Upgrade
|
| Loss (Gain) From Sale of Investments | -36.24 | -36.24 | -264.31 | -4.1 | 4.09 | -238.62 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -6.08 | -2.82 | 14.84 | 20.05 | Upgrade
|
| Other Operating Activities | -62.87 | 35.69 | 48.02 | 36.87 | 59.74 | 73.56 | Upgrade
|
| Change in Accounts Receivable | -50.94 | -50.94 | 10.95 | 37.39 | 54.92 | 254.92 | Upgrade
|
| Change in Inventory | -1.87 | -1.87 | 40.35 | 37.69 | 37.28 | 69.37 | Upgrade
|
| Change in Accounts Payable | 132.85 | 132.85 | -41.49 | 21.78 | -14.3 | -39.53 | Upgrade
|
| Operating Cash Flow | -23.67 | 59.32 | -5.55 | 35.06 | 123.27 | 123.83 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -71.55% | -0.46% | - | Upgrade
|
| Capital Expenditures | -7.54 | -4.57 | -1.38 | -10.42 | -13.52 | -38.12 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.64 | 0.6 | 65.87 | 7.51 | 118.33 | 12.01 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 0.39 | Upgrade
|
| Divestitures | - | - | - | - | 63.6 | 253.01 | Upgrade
|
| Investment in Securities | 87.52 | 88.22 | - | 5.06 | 53.31 | 12.06 | Upgrade
|
| Other Investing Activities | 0.43 | 0.43 | - | -11.52 | - | 33.31 | Upgrade
|
| Investing Cash Flow | 79.76 | 84.68 | 64.49 | -9.37 | 221.73 | 272.66 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 4.76 | Upgrade
|
| Long-Term Debt Issued | - | - | 25.9 | 158 | 184.28 | 307.93 | Upgrade
|
| Total Debt Issued | - | - | 25.9 | 158 | 184.28 | 312.69 | Upgrade
|
| Long-Term Debt Repaid | - | -143.28 | -24.13 | -177.55 | -481.49 | -674.44 | Upgrade
|
| Net Debt Issued (Repaid) | -376.16 | -143.28 | 1.77 | -19.55 | -297.21 | -361.74 | Upgrade
|
| Issuance of Common Stock | 1,926 | - | - | - | 0.67 | 18.01 | Upgrade
|
| Common Dividends Paid | -19.85 | -10.53 | -13.4 | -23.61 | -39.63 | -91.49 | Upgrade
|
| Other Financing Activities | -21.95 | -11.25 | 0.91 | -149.81 | - | 47.96 | Upgrade
|
| Financing Cash Flow | 1,509 | -165.06 | -10.72 | -192.98 | -336.17 | -387.26 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.47 | -0.24 | 0.03 | -0.09 | 0.15 | -0.06 | Upgrade
|
| Net Cash Flow | 1,564 | -21.3 | 48.25 | -167.37 | 8.98 | 9.17 | Upgrade
|
| Free Cash Flow | -31.21 | 54.76 | -6.93 | 24.64 | 109.75 | 85.72 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -77.55% | 28.04% | - | Upgrade
|
| Free Cash Flow Margin | -8.09% | 14.48% | -1.67% | 3.75% | 13.05% | 10.57% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | 0.06 | -0.01 | 0.03 | 0.13 | 0.10 | Upgrade
|
| Cash Income Tax Paid | 48.06 | 46.36 | 41.71 | 93.31 | 71.46 | 91.44 | Upgrade
|
| Levered Free Cash Flow | -59.26 | 224.84 | -43.74 | 110.2 | 187.98 | 156.56 | Upgrade
|
| Unlevered Free Cash Flow | -59.26 | 224.84 | -18.53 | 136.38 | 220.62 | 210.21 | Upgrade
|
| Change in Working Capital | 76.16 | 76.16 | 12.94 | 118 | 72.52 | 321.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.